Quick Answer
AVANOS MEDICAL, INC. reported Operating Income Loss of -$61.60 million for the year ending 2025.
- AVANOS MEDICAL, INC. showed an increase of +84.5% in Operating Income Loss from 2024 to 2025.
- This data is from AVANOS MEDICAL, INC.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2012 to 2025), AVANOS MEDICAL, INC.'s Operating Income Loss has declined by 127.0%.
- Historical annual values: Fiscal year 2025: -$61.60 million | Fiscal year 2024: -$396.20 million | Fiscal year 2023: $4.20 million | Fiscal year 2022: $35.50 million | Fiscal year 2021: -$39.00 million | Fiscal year 2020: -$48.50 million | Fiscal year 2019: -$55.70 million | Fiscal year 2018: $500.0 thousand | Fiscal year 2017: -$43.10 million | Fiscal year 2016: -$107.10 million | Fiscal year 2015: -$135.70 million | Fiscal year 2014: $94.30 million | Fiscal year 2013: $225.30 million | Fiscal year 2012: $228.00 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: